Published on: September 11, 2020 at 09:30PM
Condition: Type 1 Diabetes
Interventions: Drug: Dapagliflozin 10 MG [Farxiga]; Drug: REMD-477; Drug: Placebo
Sponsors: University of California, San Diego; REMD Biotherapeutics, Inc.
Not yet recruiting
https://ift.tt/33kqV01
Friday, 11 September 2020
New diabetes clinical trial: Combination GRA and SGLT-2i Treatment in Type 1 Diabetes
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Nothing happens without a Reason
Make Something out of it.